Co-Authors
This is a "connection" page, showing publications co-authored by MICHAEL SCHEURER and ERIK PHILIP SULMAN.
Connection Strength
0.300
-
Germline polymorphisms in MGMT associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825. Neurooncol Adv. 2022 Jan-Dec; 4(1):vdac152.
Score: 0.217
-
Genetic modulation of longitudinal change in neurocognitive function among adult glioma patients. J Neurooncol. 2022 Jan; 156(1):185-193.
Score: 0.051
-
Genetic Modulation of Neurocognitive Function in Glioma Patients. Clin Cancer Res. 2015 Jul 15; 21(14):3340-6.
Score: 0.032